Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.
BLS Polymers shares rally 6% after strong stock market debut
BLS Polymers shares extended their strong debut gains, rising nearly 6% on Wednesday after listing at a 65% premium to the IPO price. The issue